What are the causes of elevated ferritin and high thyroid‑stimulating hormone (TSH)?

Causes of Elevated Ferritin and High TSH

Elevated ferritin with high TSH most commonly indicates either inflammatory conditions causing falsely elevated ferritin alongside primary hypothyroidism, or iron overload disorders (particularly hemochromatosis) that can cause hypothyroidism as an endocrine complication.

Primary Diagnostic Framework

When encountering both elevated ferritin and high TSH, you must systematically differentiate between several distinct pathophysiologic scenarios:

1. Inflammatory/Acute Phase Response with Concurrent Hypothyroidism

Ferritin is an acute phase reactant and can be markedly elevated without true iron overload 1. The most common causes include:

• Necroinflammatory liver diseases: Alcoholic liver disease, chronic hepatitis B and C, nonalcoholic fatty liver disease (NAFLD) 1
• Lymphomas 1
• Other chronic inflammatory conditions (non-hepatic) 1, 2

In these scenarios, the elevated ferritin reflects inflammation rather than iron stores, while the elevated TSH represents separate primary hypothyroidism (autoimmune thyroiditis being most common). Check transferrin saturation (TSAT): if TSAT is <45%, iron overload is unlikely and the ferritin elevation is probably inflammatory 1.

2. Hereditary Hemochromatosis with Hypothyroidism

Hemochromatosis can directly cause hypothyroidism as an endocrine complication of iron deposition 1. The guideline evidence shows:

• Hemochromatosis patients may develop hypogonadism, hypothyroidism, and other endocrine dysfunction from iron overload 1
• Diagnosis requires: TSAT ≥45% AND elevated ferritin (>200 µg/L in women, >300 µg/L in men) 3
• Confirm with HFE genetic testing (C282Y homozygosity) 1

Critical pitfall: In hemochromatosis, ferritin >1000 µg/L with elevated liver enzymes predicts cirrhosis in 80% of cases 1. These patients require liver biopsy and hepatocellular carcinoma screening.

3. Transfusion-Related Iron Overload (Secondary Hemochromatosis)

Beta-thalassemia major patients receiving chronic transfusions develop both iron overload and hypothyroidism 4, 5, 6:

• Subclinical hypothyroidism prevalence: 10.4-15.4% in thalassemia patients 4, 5
• Ferritin cutoff of 1953 ng/mL predicts hypothyroidism development (sensitivity 85.7%, specificity 60%) 4
• TSH positively correlates with serum ferritin (r=0.34, P=0.014) 5

4. Autoimmune Hypothyroidism with Altered Iron Metabolism

Recent research reveals a complex relationship:

• Anti-TPO positive hypothyroidism shows ELEVATED ferritin, contrary to traditional teaching 7
• Anti-TPO negative hypothyroidism shows DECREASED ferritin 7
• Inverse correlation between TSH and ferritin in Hashimoto's thyroiditis 8

This suggests hypothyroidism itself may alter iron metabolism, with the direction depending on autoimmune status.

Algorithmic Approach to Diagnosis

Step 1: Measure transferrin saturation

• TSAT ≥45%: Proceed to evaluate for hemochromatosis with HFE genetic testing 1, 3
• TSAT <45%: Ferritin elevation likely inflammatory; evaluate for underlying inflammatory conditions 1, 2

Step 2: Assess for inflammation

• Check CRP, liver enzymes (ALT/AST), complete blood count 9
• If inflammatory markers elevated: ferritin is falsely elevated as acute phase reactant 2

Step 3: Evaluate thyroid status

• Confirm hypothyroidism with free T4 (should be low or low-normal in overt hypothyroidism) 10, 11
• Check anti-TPO and anti-thyroglobulin antibodies to identify autoimmune etiology 12, 7
• Exclude secondary causes: recent illness recovery, medications (dopamine, glucocorticoids), heterophilic antibodies 10, 11

Step 4: Transfusion history

• If chronic transfusions: consider secondary hemochromatosis 4, 5, 6
• Intensify iron chelation if ferritin >1953 ng/mL 4

Critical Clinical Caveats

Do not assume iron deficiency in hypothyroidism: While traditional teaching suggests hypothyroidism causes iron deficiency, anti-TPO positive autoimmune hypothyroidism actually shows elevated ferritin 7. Only anti-TPO negative hypothyroidism demonstrates reduced ferritin.

Ferritin >1000 µg/L demands aggressive evaluation: This level predicts cirrhosis in hemochromatosis and requires liver biopsy for hepatic iron concentration and histopathology 1. These patients need hepatocellular carcinoma surveillance.

Timing of repeat testing matters: After IV iron administration, wait 8-10 weeks before rechecking ferritin, as levels are falsely elevated immediately post-infusion 9.

Pregnancy considerations: TSH normally falls in first trimester due to hCG; use trimester-specific reference ranges 10. Hemoglobin correlates more strongly with thyroid function than ferritin during pregnancy 13.

Treatment Implications

The combination of elevated ferritin and high TSH affects management:

• If hemochromatosis confirmed: Therapeutic phlebotomy targeting ferritin <50 µg/L (induction) and <100 µg/L (maintenance) 3, plus thyroid hormone replacement
• If inflammatory: Treat underlying condition; ferritin will normalize as inflammation resolves 2
• If autoimmune hypothyroidism: Levothyroxine replacement; monitor ferritin as it may normalize with thyroid hormone therapy 7, 8
• If transfusion-related: Intensify iron chelation when ferritin >1953 ng/mL 4